Ebel F, Thieringer FM, Kunz C, Klein-Franke A, Scheinemann K, Guzman R, et al
"Apart from glycaemic effects, both doses of ecnoglutide induced statistically significantly greater reductions in bodyweight, waist circumference, hip circumference, and triglycerides, all of which are cardiovascular risk factors, than dulaglutide," write the researchers
Many men see meaningful increases as visceral fat decreases and aromatase activity drops
The study indicates tirzepatide's combined approach leads to greater weight loss
Compounded semaglutide is not FDA-approved and is not interchangeable with brand-name Ozempic
Exercise is associated with a reduction in the markers of liver inflammation and may help liver cells stay healthy